Melih O. Babaoğlu

780 total citations
43 papers, 509 citations indexed

About

Melih O. Babaoğlu is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Melih O. Babaoğlu has authored 43 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Pediatrics, Perinatology and Child Health and 10 papers in Oncology. Recurrent topics in Melih O. Babaoğlu's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Melih O. Babaoğlu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Melih O. Babaoğlu collaborates with scholars based in Türkiye, Sweden and Germany. Melih O. Babaoğlu's co-authors include Atilla Bozkurt, Ümit Yaşar, Reinhold Kerb, İ. Çelik, Arzu Gunes, Hüseyin Abalı, Hakan Zengil, Mutlu Hayran, Ali Akdoğan and Meral Çalgünerı and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Melih O. Babaoğlu

40 papers receiving 489 citations

Peers

Melih O. Babaoğlu
B Kattman United States
Marianne Kristiansen Kringen Norway
G. G. Duggin Australia
Takanobu Matsuzaki Japan
Muradiye Nacak Türkiye
Michael J. Knauer Canada
Kyoko Matsuguma Japan
MJ Langman United Kingdom
Marie-Paule Gascon Switzerland
Patrick Mayo Canada
B Kattman United States
Melih O. Babaoğlu
Citations per year, relative to Melih O. Babaoğlu Melih O. Babaoğlu (= 1×) peers B Kattman

Countries citing papers authored by Melih O. Babaoğlu

Since Specialization
Citations

This map shows the geographic impact of Melih O. Babaoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melih O. Babaoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melih O. Babaoğlu more than expected).

Fields of papers citing papers by Melih O. Babaoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melih O. Babaoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melih O. Babaoğlu. The network helps show where Melih O. Babaoğlu may publish in the future.

Co-authorship network of co-authors of Melih O. Babaoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Melih O. Babaoğlu. A scholar is included among the top collaborators of Melih O. Babaoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melih O. Babaoğlu. Melih O. Babaoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karahan, Sevilay, et al.. (2025). Association of Endothelial Nitric Oxide Synthase Polymorphisms with Clinical Severity in Patients with COVID-19. Journal of Clinical Medicine. 14(6). 1931–1931. 1 indexed citations
2.
3.
Babaoğlu, Melih O., et al.. (2022). The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension. SHILAP Revista de lepidopterología. 47(3). 1015–1023.
4.
Phương, Nguyễn Thị Thu, Jin Ah Jung, Jong‐Lyul Ghim, et al.. (2021). Para‐aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research. British Journal of Clinical Pharmacology. 88(3). 1159–1169. 4 indexed citations
5.
6.
Yağcıoğlu, A. Elif Anıl, et al.. (2016). Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine. Journal of Clinical Psychopharmacology. 36(3). 257–261. 12 indexed citations
7.
Kılıç, Levent, Ali Akdoğan, Melih O. Babaoğlu, et al.. (2015). Lower CYP2C9 activity in Turkish patients with Behçet’s disease compared to healthy subjects: a down-regulation due to inflammation?. European Journal of Clinical Pharmacology. 71(10). 1223–1228. 10 indexed citations
8.
Güler, S., et al.. (2013). Propranolol-induced relaxation in the rat basilar artery. Vascular Pharmacology. 58(4). 307–312. 9 indexed citations
9.
Gümüş, Ersin, Melih O. Babaoğlu, Gökhan Baysoy, et al.. (2011). Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype–phenotype correlation in childhood. European Journal of Clinical Pharmacology. 68(5). 629–636. 37 indexed citations
10.
Yaşar, Ümit, et al.. (2011). Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients. Basic & Clinical Pharmacology & Toxicology. 109(2). 73–77. 10 indexed citations
11.
Güngör, Sirel Gür, Yonca A. Akova, Atilla Bozkurt, et al.. (2010). Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. British Journal of Ophthalmology. 95(9). 1272–1275. 10 indexed citations
12.
Sivaslı, Ercan, Melih O. Babaoğlu, Ümit Yaşar, et al.. (2010). Association between the Glu298Asp and T(-786)C polymorphisms of the endothelial nitric oxide synthase gene and respiratory distress in preterm neonates.. PubMed. 52(2). 145–9. 3 indexed citations
13.
Yaşar, Ümit, Melih O. Babaoğlu, & Atilla Bozkurt. (2008). Disposition of a CYP2C9 Phenotyping Agent, Losartan, Is Not Influenced by the Common 3435C > T Variation of the Drug Transporter Gene ABCB1 (MDR1). Basic & Clinical Pharmacology & Toxicology. 103(2). 176–179. 8 indexed citations
14.
Dericioğlu, Neşe, et al.. (2008). Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene. Epilepsy Research. 80(1). 42–46. 24 indexed citations
15.
Yaşar, Ümit, et al.. (2006). Tamoxifen Inhibits Cytochrome P450 2C9 Activity in Breast Cancer Patients. Journal of Chemotherapy. 18(4). 421–424. 18 indexed citations
16.
Gunes, Arzu, Uğur Çoşkun, Nazan Günel, et al.. (2006). Inhibitory Effect of 5‐Fluorouracil on Cytochrome P450 2C9 Activity in Cancer Patients. Basic & Clinical Pharmacology & Toxicology. 98(2). 197–200. 30 indexed citations
17.
Yaşar, Ümit, et al.. (2006). Variant alleles and genotypes of alcohol dehydrogenase 3 in aTurkish population. Methods and Findings in Experimental and Clinical Pharmacology. 28(4). 229–229. 3 indexed citations
18.
Babaoğlu, Melih O., et al.. (2005). Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists. Clinical Pharmacology & Therapeutics. 78(6). 619–626. 58 indexed citations
19.
Babaoğlu, Melih O., Turgay Öcal, Banu Bayar, S.O. Kayaalp, & Atilla Bozkurt. (2004). Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population. European Journal of Clinical Pharmacology. 59(12). 875–877. 17 indexed citations
20.
Babaoğlu, Melih O., et al.. (2001). Polymorphic variant endothelial nitric oxide synthase impairs endothelium dependent vascular relaxation in both heterozygotes and homozygotes. Clinical Pharmacology & Therapeutics. 69(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Kattman Breakdown of academic impact, for papers by Marianne Kristiansen Kringen Breakdown of academic impact, for papers by G. G. Duggin Breakdown of academic impact, for papers by Takanobu Matsuzaki Breakdown of academic impact, for papers by Muradiye Nacak Breakdown of academic impact, for papers by Michael J. Knauer Breakdown of academic impact, for papers by Kyoko Matsuguma Breakdown of academic impact, for papers by MJ Langman Breakdown of academic impact, for papers by Marie-Paule Gascon Breakdown of academic impact, for papers by Patrick Mayo
Rankless by CCL
2026